Is ZYNTEGLO right for your patient?
CONSIDER TREATMENT FOR PATIENTS WHO MEET THESE CRITERIA:
Diagnosed with TDT1
Who do not have a β0/β0 genotype1
Patients ≥12 years of age1
Appropriate for HSCT1
No HLA–matched related HSC donor available1
- Hypersensitivity to the active substance or to any of the excipients1
- Pregnancy and breastfeeding1
- Previous treatment with HSC gene therapy1
- Contraindications to the mobilisation agents and the myeloablative conditioning agent must be considered1
Please consult the full EU Summary of Product Characteristics (EU SmPC) before prescribing.